Cuvitru

Cuvitru is a subcutaneous immunoglobulin therapy designed to support immune function. Learn about its uses, effects, and precautions for managing immune-related conditions.

Cuvitru is primarily used to treat primary immunodeficiency disorders, providing essential antibodies to support the immune system. It is administered subcutaneously, offering a convenient and effective method for long-term immune support. Patients often inquire, 'What is Cuvitru used for?' to understand its role in managing immune deficiencies.

Common effects of Cuvitru may include localized reactions at the injection site, such as redness or swelling. Some users also report mild systemic effects like fatigue or headache. These effects are generally temporary and vary among individuals.

Cuvitru should be handled with care, ensuring proper storage and administration as directed. Patients with a history of severe allergic reactions to immunoglobulin products should consult their healthcare provider before use. Always follow the prescribed guidelines for subcutaneous administration.

Cuvitru may interact with certain medications, particularly those that affect the immune system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances that affect immune function should also be considered.